文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > A Novel Link Between SUMO Modification and Cancer Metastasis
侵权投诉

A Novel Link Between SUMO Modification and Cancer Metastasis

A Novel Link Between SUMO Modification and Cancer Metastasis

5.Shevde LA, Welch DR. Metastasis suppressor pathways-an evolving paradigm. Cancer Lett2003; 198:1-20.

6.Steeg PS. Metastasis suppressors alter the signal transduction of cancer cell. Nature RevCancer 2002; 3:55-63.

7.Petrylak DP. Metastases suppressors and prostate cancer. Nature Med 1995; 1:739-40.8.Kim JH, Kim B, Cai L, Choi HJ, Ohgi KA, Tran C, Chen C, Chung CH, Huber O, RoseDW, Sawyers CL, Rosenfeld MG, Baek SH. Transcriptional regulation of a metastasis sup-pressor gene by Tip60and β-catenincomplexes. Nature 2005; 434:921-6.

9.Kim JH, Choi HJ, Kim B, Kim MH, Lee JM, Kim IS, Lee MH, Choi SJ, Kim KI, KimSI, Chung CH, Baek SH. Roles of SUMOylation of a reptin chromatin-remodeling com-plex in cancer metastasis. Nature Cell Biol 2006; 8:631-9.

10.Ikura T, Ogryzko VV, Grigoriev M, Groisman R, Wang J, Horikoshi M, Scully R, Qin J,

Nakatani Y. Involvement of the TIP60 histone acetylase complex in DNA repair and apop-tosis. Cell 2000; 102:463-73.

11.Baek SH, Ohgi KA, Rose, DW, Koo, EH, Glass CK, Rosenfeld MG. Exchange of N-CoR

corepressor and Tip60 coactivator complexes links gene expression by NF-κBand β-amy-loidprecursor protein. Cell 2002; 110:55-67.

12.Feng Y, Lee N, Fearon ER. TIP49regulates β-catenin-mediated neoplastic transformation

and T-cellfactor target gene induction via effects on chromatin remodeling. Cancer Res2003; 63:8726-34.

13.Kanemaki M, Kurokawa Y, Matsu-ura T, Makino Y, Masani A, Okazaki K, Morishita T,

Tamura TA. TIP49b, a new RuvB-like DNA helicase, is included in a complex togetherwith another RuvB-like DNA helicase, TIP49a. J Biol Chem 1999; 274:22437-44.

14.Jonsson ZO, Jha S, Wohlschlegel JA, Dutta A. Rvb1p/Rvb2p recruits Arp5p and assemble

a functional Ino80 chromatin remodeling complex. Mol Cell 2004; 16:465-77.

15.Francis NJ, Saurin AJ, Shao Z, Kingston RE. Reconstitution of a functional core polycomb

repressive complex. Mol Cell 2001; 8:545-56.

16.Bauer A, Chauvet S, Huber O, Usseglio F, Rothbacher U, Aragnol D, Kemler R, Pradel J.

Pontin52 and Reptin52 function as antagonistic regulators of β-catenin signaling activity.EMBO J 2000; 19:6121-30.

17. Rottbauer W, Saurin AJ, Lickert H, Shen X, Burns CG, Wo ZG, Kemler R, Kingston R,

Fishman M. Reptin and pontin antagonistically regulate heart growth in zebrafish embryos.Cell 2002; 111:661-72.

18.Billin AN, Thirlwell H, Ayer DE. β-catenin-histone deacetylase interactions regulate the

transition of LEF1 from a transcriptional repressor to an activator. Mol Cell Biol 2000;20:6882-90.

19.Baek SH, Kioussi C, Briata P, Wang D, Nguyen HD, Ohgi KA, Glass CK, Wynshaw-Boris

A, Rose DW, Rosenfeld MG. Regulated subset of G1growth-control genes in response toderepression by the Wntpathway. Proc Natl Acad Sci USA 2003; 100:3245-50.

20.Cheshire DR, Isaacs WB. β-Catenin signaling in prostate cancer: An early perspective.

Endocr Relat Cancer 2003; 10:537-60.

21.Clever H. Wnt breakers in colon cancer. Cancer Cell 2004; 5:5-6.

22.Moon RT, Bowerman B, Boutros M, Perrimon N. The promise and perils of Wnt signal-ing through β-catenin. Science 2002; 296:1644-6.

23.Chesire DR, Ewing CM, Gage WR, Isaacs WB. In vitro evidence for complex modes of

nuclear β-cateninsignaling during prostate growth and tumorigenesis. Oncogene 2002;21:2679-94.

24.Seeler JS, Dejean A. Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol

2003; 4:690-9.

25.Gill G. SUMOand ubiquitin in the nucleus: Different functions, similar mechanisms?

Genes Dev 2004; 18:2046-59.

26.Ulrich HD. Mutual interactions between the SUMO and ubiquitin systems: A plea of no

contest. Trends Cell Biol 2005; 15525-32.

27.Hay RT. SUMO: A history of modification. Mol Cell 2005; 18:1-12.

28.Garcia-Wilson E, Perkins ND. P21WAF1/CIP1 regulates the p300 SUMOylation motif

CRD1 through a C-terminal domain independently of Cyclin/CDK binding. Cell Cycle2005; 4:1113-9.

29.Boggio R, Chiocca S. Gam1 and the SUMO pathway. Cell Cycle 2005; 4:533-5.

30.Rizos, H, Woodruff S, Kefford RF. P14ARF interacts with the SUMO-conjugating enzyme

Ubc9 and promotes the sumoylation of its binding partners. Cell Cycle 2005; 4:597-603.31.Johnson ES. Protein modification by SUMO. Annu Rev Biochem 2004; 73:355-82.

32.Kim KI, Baek SH, Chung CH. Versatile protein tag, SUMO: Its enzymology and biolog-ical function. J Cell Physiol 2002; 191:257-268.

33.Haracska L, Torres-Romos CA, Johnson RE, Prakash S, Prakash L. Opposing effects of

ubiquitin conjugation and SUMO modification of PCNA on replicational bypass of DNAlesions in Saccharomyces cerevisiae. Mol Cell Biol 2004; 24:4267-74.

34.Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, Jentsch S. RAD6-dependent DNA

repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 2002;419:135-141.

35.Ulrich HD, Vogel S, Davies AA. SUMO keeps a check on recombination during DNA

replication. Cell Cycle 2005; 4:1699-1702.

36.Li SJ, Hochstrasser M. A new protease required for cell-cycle progression in yeast. Nature

1999; 398:246-51.

37.Kim KI, Baek SH, Jeon YJ, Nishimori S, Suzuki T, Uchida S, shimbara N, Saitoh H,

Tanaka K, Chung CH. A new SUMO-1-specific protease, SUSP1, that is highly expressedin reproductive organs. J Biol Chem 2000; 275:14102-6.

38.Bachant J, Alcasabas A, Blat Y, Kleckner N, Elledge SJ. The SUMO-1 isopeptidase Smt4

is linked to centromeric cohesion through SUMO-1 modification of DNA topoisomeraseII. Mol Cell 2002; 9:1169-82.

39.Muller S, Matunis MJ, Dejean A. Conjugation with the ubiquitin-related modifier

SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 1998; 17:61-70.40.Buschmann T, Fuchs SY, Lee CG, Ronai Z. SUMO-1 modification of mdm2 prevents its

self-ubiquitination and increases mdm2 ability to ubiquitinate p53. Cell 2000;101:753-62.

41.Bies J, Markus J. Wolff L. Covalent attachment of SUMO-1 protein to the negative regu-latory domain of the c-Myb transcription factor modifies its stability and transactivationcapacity. J Biol Chem 2002; 277:8999-9009.

42.Schmidt D, Muller S. Members of the PIAS family acts as SUMO ligases for c-Jun and p53

and repress p53 activity. Proc Natl Acad Sci USA 2002; 99:2872-7.

43.Huang YP, Wu G, Guo Z, Osada M, Fomenkov T, Park HL, Trink B, Sidransky D,

Fomenkov A, Ratovitski EA. Altered sumoylation of p63 contricutes to the split-hand/footmalformation phenotype. Cell Cycle 2004; 3:1587-96.

44.Besten WD, Kuo ML, Williams RT, Sherr CJ. Myeloid leukemia-associated nucleophos-min mutants perturb p53-dependent and independent activities of the Arftumor suppres-sor protein. Cell Cycle 2005; 4:1593-8.

45.Ghioni P, D’lessandra Y, Mansueto G, Jaffray E, Hay RT, Lantria GL, Guerrini L. The pro-tein stability and transcriptional activity of p63 are regulated by SUMO-1 conjugation.Cell Cycle 2005; 4:183-90.

46.Ghosh M, Weghorst K, Berberich SJ. MdmX inhibits ARF mediated Mdm2 sumoylation.

Cell Cycle 2005; 4:604-8.

47.Alarcon-Vargas D, Ronai Z. SUMO in cancer-Wrestlers wanted. Cancer Biol and Therapy

2002; 1:237-42.

doc.guandang.net Cycle1495

上一页第4页

你可能喜欢

热门文档

相关文档

  • Breast cancer adaptive resistance

    our laboratory showed that HER2 is a novel breast...it is plausible to suggest a link between the ...Cancer Metastasis Rev 14:49–58 O’Brien KM, ...

  • Breast cancer adaptive resistance

    our laboratory showed that HER2 is a novel breast...it is plausible to suggest a link between the ...Cancer Metastasis Rev 14:49–58 O’Brien KM, ...

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email